Value Bridge — BAYSTATE MEDICAL CENTER
Current $-219M → Target $-187M (+$32.3M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-219.1M
Current EBITDA
$-186.8M
Target EBITDA
+$32.3M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$7.3M
Payer Mix Optimization
$17.5M
Cost to Collect Reduction
$5.8M
Clean Claim Improvement
$4.4M
Volume & Rate Growth
$29.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-219M to $-187M. The highest-impact lever is Volume & Rate Growth at $11.7M probability-weighted.
IC talking point: "We see $32M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $355M in equity value creation."